Tag Archives: trial

Magic Medicine

Can magic mushrooms cure depression?

Over two years we follow the first ever medical trial of psilocybin (the psychoactive ingredient in magic mushrooms) being used to treat a group of volunteers suffering from clinical depression.

This remarkable film follows three volunteers and their families, and the ambitious staff running the trial, who are hoping this controversial treatment will have the power to transform millions of lives.

With deeply moving footage of the ‘trips’ the patients go on, as well as interviews providing scientific and political context, this intimate film is an absorbing portrait of the human cost of depression, and the inspirational people contributing to groundbreaking psychedelic research.

 

—

 

“Monty Wates’s documentary shows the work of Dr Robin Carhart-Harris at Imperial College London: after years of bureaucratic wrangling, he got permission to conduct research into the possibility that psilosybin – the psychoactive ingredient of magic mushrooms – could be used to treat depression. Is society’s taboo disapproval needlessly holding back our understanding of this issue?

We see three long-time sufferers of depression, sensitively interviewed about their lives… They are given a low, introductory dose of shroom-essence at the first session, and at the second the amount is stepped up. The results are startling”

Peter Bradshaw, The Guardian

 

Burzynski: Cancer Cure Cover Up

Burzynski: The Cancer Cure Cover-up is the story of a pioneering biochemist who discovered a unique and proprietary method of successfully treating most cancers. This documentary takes the audience on a near 50-year journey both Dr. Burzynski and his patients have been enduring in order to obtain FDA-approved clinical trials of Antineoplastons. Defying the face of skepticism, legal attacks from state and federal agencies, and a powerful propaganda campaign to stop Burzynski – this doctor and his patients are still going strong.

Due to the continued failed efforts of state and federal agencies in their attempts to stop Burzynski from continuing to treat patients and expand his research, special interest groups have since launched a relentless propaganda campaign against Dr. Burzynski, and his supporters and patients, in hopes  that this game-changing innovation never reach the open market.

The primary reason that the cancer industry and its regulatory agencies fear the approval of Antineoplastons is purely economical.

If Antineoplastons were FDA-approved for just one cancer type this would mean that anyone of any age diagnosed with any type of cancer could legally insist their oncologist provide them with Antineoplastons “off-label”.   Given the gentle and nontoxic nature of these medications, most people would begin to opt for Antineoplastons as a first line of defense against their cancer instead of first choosing life-threatening yet profitable chemotherapy and radiation.

Burzynski: The Cancer Cure Cover-up investigates this hidden cancer treatment and the decades of failed lawsuits the US government and FDA have pursued in order to try to silence him.